| Xiao dan Yang,Tao Han,Yue Zhang,Yanming Zhang,Gao Li,Yongye Liu,Zhaozhe Liu,Zhendong Zheng. The application of 3D printing in the development of RECIST standard for evaluating tumor efficacy. Oncol Transl Med, 2020, 6: 39-42. |
| The application of 3D printing in the development of RECIST standard for evaluating tumor efficacy |
| Received:August 19, 2019 Revised:September 11, 2019 |
| View Full Text View/Add Comment Download reader |
| KeyWord:Three-dimensional (3D) printing; RECIST standard; chemotherapy |
| Author Name | Affiliation | E-mail | | Xiao dan Yang | General Hospital of Northern Theater Command | yxdoctor_88@163.com | | Tao Han | General Hospital of Northern Theater Command | | | Yue Zhang | Jinzhou Medical University | | | Yanming Zhang | Jinzhou Medical University | | | Gao Li | Shenyang Pharmaceautical University | | | Yongye Liu | General Hospital of Northern Theater Command | | | Zhaozhe Liu | General Hospital of Northern Theater Command | | | Zhendong Zheng | General Hospital of Northern Theater Command | zhengzhdong@163.com |
|
| Hits: 6801 |
| Download times: 8619 |
| Abstract: |
| Three-dimensional (3D) printing technology, as a novel technical method, can convert conventional
computed tomography (CT) or magnetic resonance imaging (MRI) scans to computer-aided design files
and develop a 2D spatial structure into a 3D imaging structure. In recent years, the technology has been
widely used in numerous areas, including head and neck surgery, orthopedics, and bio-medicinal research.
This article uses examples of 3D printed tumor models to develop Response Evaluation Criteria In Solid
Tumors (RECIST) standards to evaluate the changes in tumors. RECIST standard is currently recognized
as the standard for assessment of chemotherapy. Under the RECIST standard, changes occurring in tumors
before and after the surgery, are evaluated. The assessment depends upon a CT evaluation of the changes
in the lesions with the largest diameters. In addition, the disease progression and stability of remission
is also assessed. Three-dimensional printing technology is more intuitive in the evaluation of changes to
human tumors following chemotherapy and targeted therapy. However, a few reports are available. |
| Close |
|
|
|